Anlotinib Completed Phase 1 Trials for Cancer, Advanced Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT02825563A Phase I Study of Anlotinib on Pharmacokinetics to Assess the Effect of High Fat Diet in Advanced Cancer Patients
NCT01833923A Phase I Study of Anlotinib on Tolerance and Pharmacokinetics